01 1MERCK SHARP DOHME
02 5MSD SUB MERCK
01 67754731
01 6Y
01 6Y
01 62029-03-11
Patent Expiration Date : 2029-03-11
LAMIVUDINE; RALTEGRAVIR POTASSIUM
US Patent Number : 7754731
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 206510
Patent Use Code : U-1663
Delist Requested :
Patent Use Description : TREATMENT OF HIV-1 INF...
Patent Expiration Date : 2029-03-11
Patent Expiration Date : 2029-03-11
US Patent Number : 7754731
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205786
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-03-11
Patent Expiration Date : 2029-03-11
US Patent Number : 7754731
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203045
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-03-11
Patent Expiration Date : 2029-03-11
US Patent Number : 7754731
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22145
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-03-11
Patent Expiration Date : 2029-03-11
US Patent Number : 7754731
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 22145
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-03-11
Patent Expiration Date : 2029-03-11
US Patent Number : 7754731
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203045
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-03-11
